sec filing
CT
NASDAQ · CTSO
Cytosorbents Corp.
Healthcare · Medical - Devices
$3.97
Down-$0.01 (-0.13%)
Updated Oct 6, 2026, 10:38 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 45.22M
- P/E ratio
- -4.27
- Dividend yield
- 0.00%
- 52-week range
- $0.30 – $9.43
- Volume
- 8.38K
- Avg. volume
- 95.06K
Price performance · CTSO
CTSO price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
CTSO closed at $3.97 after 20 trading sessions, down 42.12% for the selected period.
- Last close
- $3.97
- Period change
- -42.12%
- Period low
- $3.90
- Period high
- $6.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $3.85 | $4.05 | $3.66 | $3.965 | 8.38K |
| Oct 2, 2026 | $4.17 | $4.29 | $3.83 | $4.05 | 12.55K |
| Oct 1, 2026 | $4.38 | $4.50 | $3.93 | $4.185 | 8.27K |
| Sep 30, 2026 | $4.13 | $4.15 | $3.765 | $3.90 | 13.67K |
| Sep 29, 2026 | $4.08 | $4.48 | $4.00 | $4.00 | 9.81K |
| Sep 28, 2026 | $4.28 | $4.565 | $3.97 | $4.02 | 14.26K |
| Sep 25, 2026 | $4.44 | $4.8275 | $4.33 | $4.38 | 6.53K |
| Sep 24, 2026 | $5.20 | $5.20 | $3.94 | $4.30 | 24.87K |
| Sep 23, 2026 | $5.25 | $5.36 | $4.895 | $4.91 | 6.11K |
| Sep 22, 2026 | $5.53 | $5.59 | $5.31 | $5.32 | 6.35K |
| Sep 21, 2026 | $5.79 | $5.79 | $5.16 | $5.51 | 14.27K |
| Sep 18, 2026 | $5.88 | $6.00 | $5.50 | $5.75 | 11.77K |
| Sep 17, 2026 | $5.96 | $5.96 | $5.7501 | $5.76 | 3.07K |
| Sep 16, 2026 | $6.03 | $6.11 | $5.56 | $5.73 | 4.91K |
| Sep 15, 2026 | $6.00 | $6.2388 | $6.00 | $6.06 | 12K |
| Sep 14, 2026 | $6.33 | $6.3436 | $5.13 | $6.0699 | 9.36K |
| Sep 11, 2026 | $6.50 | $6.615 | $6.32 | $6.41 | 12.09K |
| Sep 10, 2026 | $6.37 | $6.74 | $6.25 | $6.37 | 14.39K |
| Sep 9, 2026 | $6.74 | $6.98 | $6.11 | $6.33 | 36.92K |
| Sep 8, 2026 | $6.76 | $7.44 | $6.75 | $6.85 | 18.13K |
Latest CTSO news
The latest Smart Investors Daily articles mentioning CTSO.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…